Literature DB >> 10809167

Investigation on the mechanism involved in the effects of agmatine on ethanol-induced gastric mucosal injury in rats.

T Utkan1, G Ulak, H G Yildiran, M Yardimoglu, M N Gacar.   

Abstract

Effects of agmatine, an endogenous metabolite formed by decarboxylation of L-arginine, on ethanol-induced gastric mucosal injury were investigated in rats. Agmatine at 1 and 10 mg/kg i.p doses significantly increased ethanol-induced gastric mucosal injury. This effect of agmatine was abolished completely by pretreatment with idazoxan, an imidazoline receptor-antagonist and alpha2 receptor- antagonist, (0.5 mg/kg i.p), partly by yohimbine, an alpha2 receptor- antagonist, (1 mg/kg i.p) but not by L-arginine, a precursor of nitric oxide, (500 mg/kg i.p). Our results suggest that agmatine had a potent ulcerogenic effect mediated, at least in part, by both alpha2-adrenoceptors and imidazoline receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809167     DOI: 10.1016/s0024-3205(00)00493-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Agmatine induces gastric protection against ischemic injury by reducing vascular permeability in rats.

Authors:  Abeer A Al Masri; Eman El Eter
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

2.  Involvement of alpha(2)-adrenoceptors in the gastric protective effect of nitroglycerin against acidified ethanol-induced mucosal injury.

Authors:  Felix W Leung; Chi Chung Chan
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

3.  Gastroprotective and antioxidant effects of fluvoxamine on stress-induced peptic ulcer in rats.

Authors:  Wael M Elsaed; Abdulaziz M Alahmadi; Basil T Al-Ahmadi; Jumana A Taha; Raghad M Tarabishi
Journal:  J Taibah Univ Med Sci       Date:  2018-05-31

4.  Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.

Authors:  Hakan Dursun; Mehmet Bilici; Fatih Albayrak; Cengiz Ozturk; Mustafa B Saglam; Hamit H Alp; Halis Suleyman
Journal:  BMC Gastroenterol       Date:  2009-05-20       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.